Medication-Assisted Treatment for Fentanyl Addiction in Los Angeles

Choosing the right medication is a clinical decision made collaboratively between the patient and our prescribing physician. Each medication has a distinct profile of benefits, risks, and lifestyle requirements that must be weighed carefully.

Buprenorphine/naloxone (Suboxone) is a partial opioid agonist that reduces cravings and prevents withdrawal without producing the full euphoric effect of fentanyl. It can be prescribed for take-home use relatively quickly, making it practical for patients who need to maintain work or family responsibilities. The naloxone component discourages misuse by causing withdrawal if the medication is injected.

Methadone is a full opioid agonist dispensed daily at licensed clinics. It is particularly effective for patients with severe fentanyl dependence or those who have not responded to buprenorphine. Because methadone can only be dispensed through a federally licensed opioid treatment program and requires daily clinic attendance initially, it provides structured accountability alongside medication.

Naltrexone (Vivitrol) works differently; it is an opioid antagonist that blocks the euphoric effects of opioids entirely. It is most appropriate for patients who have already completed medically supervised detox and are fully opioid-free. The monthly injectable form removes the daily adherence burden.

The MAT process at iRely begins before any medication is dispensed. Our intake team conducts a full biopsychosocial assessment to understand your history with fentanyl, any co-occurring mental health conditions, and your goals for recovery. This evaluation guides every clinical decision that follows.

Induction, the process of starting medication, is carefully monitored. For buprenorphine, this typically begins when mild to moderate withdrawal symptoms are present, which is usually 12 to 24 hours after the last fentanyl use for most forms, though fentanyl's long tissue half-life sometimes requires extended monitoring. Methadone induction follows a strict dosing protocol to avoid sedation or respiratory depression.

During stabilization, our team works to find the dose that eliminates cravings without causing sedation. This phase can take days to weeks and requires honest communication about how you are feeling. Concurrent counseling sessions begin immediately, medication alone is not sufficient for lasting recovery.

At iRely Recovery, medication is one component of a comprehensive treatment plan; it is never the only component. Research is unambiguous: MAT combined with counseling produces significantly better outcomes than either medication or therapy alone. Our clinical schedule integrates individual therapy, group sessions, and skills-based programming alongside medical management visits.

Individual therapy sessions use evidence-based modalities including Cognitive Behavioral Therapy (CBT), Motivational Interviewing (MI), and trauma-focused approaches when indicated. CBT helps patients identify the thought patterns and triggers that drive fentanyl use and develop concrete coping strategies. Motivational Interviewing strengthens internal motivation and resolves ambivalence about change, a critical factor in early recovery.

Group therapy provides peer connection that medications cannot replicate. Sharing experiences with others in recovery reduces the shame and isolation that sustain addiction. Our groups are facilitated by licensed clinicians and cover relapse prevention, relationships, co-occurring disorders, and life skills.